Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...

Receptor Tyrosine Kinases

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Loss of erythrocyte arginase-1 impairs vasorelaxation due to endothelial GSNOR overexpression and denitrosylation of G protein subunits.

Redox biology·2026

Same author

Oligodendrocyte mechanotransduction channel TMEM63A regulates myelin sheath geometry.

Neuron·2026

Same author

Nuclear Ca<sup>2+</sup>-Calmodulin signaling in cardiac myocytes reduces catecholamine-evoked protein translation and prevents hypertrophy.

Cell calcium·2025

Same author

TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia.

The EMBO journal·2024

Same author

OCaR1 endows exocytic vesicles with autoregulatory competence by preventing uncontrolled Ca2+ release, exocytosis, and pancreatic tissue damage.

The Journal of clinical investigation·2024

Same author

Membrane-bound Interleukin-1α mediates leukocyte adhesion during atherogenesis.

Frontiers in immunology·2023

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Published on: September 22, 2011

Rho kinase and hypertension.

¹Max-Planck-Institute for Heart and Lung Research, Dept. of Pharmacology, Ludwigstraße 43, 61231 Bad Nauheim, Germany. Angela.Wirth@pharma.uni-heidelberg.de

Biochimica Et Biophysica Acta

|May 13, 2010

Summary

Arterial hypertension involves increased vascular resistance, linked to Rho kinases (ROCKs). Targeting the RhoA/ROCK pathway, through inhibitors or other agents, offers cardiovascular benefits by influencing smooth muscle function.

Area of Science:

Cardiovascular Science
Molecular Biology
Pharmacology

Background:

Arterial hypertension is characterized by elevated peripheral vascular resistance and smooth muscle cell alterations.
Rho kinases (ROCKs), effectors of the RhoA signaling pathway, are implicated in cardiovascular diseases, including hypertension.
The RhoA/ROCK pathway regulates critical smooth muscle cell functions like contractility, proliferation, and migration.

Purpose of the Study:

To explore the role of the RhoA/ROCK signaling pathway in arterial hypertension.
To investigate the interplay between RhoA/ROCK and nitric oxide (NO) signaling in cardiovascular regulation.
To elucidate the mechanisms by which ROCK inhibitors, NO-donors, and statins exert beneficial cardiovascular effects.

Main Methods:

More Related Videos

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Assessing Murine Resistance Artery Function Using Pressure Myography

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

Related Experiment Videos

Last Updated: Jun 13, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Published on: September 22, 2011

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Assessing Murine Resistance Artery Function Using Pressure Myography

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

Review of existing literature on RhoA/ROCK signaling in cardiovascular disease.

Analysis of the functional roles of ROCK in smooth muscle cells.

Examination of the crosstalk between RhoA/ROCK and NO signaling pathways.

Main Results:

Abnormalities in RhoA/ROCK signaling are frequently observed in hypertension.
The RhoA/ROCK pathway is pivotal in modulating vascular smooth muscle contractility, proliferation, and migration.
Significant crosstalk exists between RhoA/ROCK and NO signaling, influencing vascular tone and function.

Conclusions:

The RhoA/ROCK pathway is a key contributor to the pathophysiology of arterial hypertension.
Modulation of the RhoA/ROCK pathway, via ROCK inhibitors or other therapeutic agents, holds promise for cardiovascular disease treatment.
Therapeutic strategies targeting RhoA/ROCK signaling, including NO-donors and statins, demonstrate cardiovascular benefits partly through this pathway.